Planned ANAB share sale follows prior insider trade (NASDAQ: ANAB)
Rhea-AI Filing Summary
AnaptysBio insider files to sell common stock under Rule 144. A holder plans to sell 4,219 shares of common stock through Morgan Stanley Smith Barney LLC on or about 01/05/2026 on NASDAQ, with an aggregate market value of $189,644.05. The filing notes 28,023,368 shares of the issuer’s common stock outstanding, providing a baseline for the company’s share count. The shares to be sold were acquired as restricted stock units from the issuer on 01/05/2026, with payment listed as cash on the same date.
The form also reports that Paul F. Lizzul sold 1,500 common shares on 12/22/2025 for gross proceeds of $75,000 during the prior three months. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.
Positive
- None.
Negative
- None.